Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Metronidazole
Teva Pharma GmbH
Healthy
1 trial -
Metronidazole + MMX Mesalazine/mesalamine placebo
Takeda
Healthy
1 trial -
Microgestin®
IRONWOOD PHARMACEUTICALS INC
Healthy Volunteers
1 trial -
Midazolam
Takeda
Healthy
1 trial -
Midazolam
Takeda
Healthy Volunteers
1 trial -
Midazolam Syrup
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Subjects
1 trial -
Midazolam hydrochloride
CORCEPT THERAPEUTICS INC
Healthy
1 trial -
Mifepristone
CORCEPT THERAPEUTICS INC
Healthy
1 trial -
Minzasolmin, UCB0599 PRD4385815
Lacuna Pharma Pty Ltd
Healthy Participants
1 trial -
Mirasol System for Whole Blood.
United Therapeutics Europe Ltd
Healthy
1 trial -
Miricorilant 300 mg tablets
CORCEPT THERAPEUTICS INC
Healthy
1 trial -
Miricorilant Treatment A
CORCEPT THERAPEUTICS INC
Healthy
1 trial -
Mirtazapine 15 mg (Orally Disintegrating) Tablets
Teva Pharma GmbH
Healthy
2 trials -
Mitapivat
Agios Netherlands B.V.
Healthy Participants
1 trial -
Mitapivat tablet
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
Mitapivat tablets
Agios Netherlands B.V.
Healthy Volunteers
1 trial -
Mobocertinib
Takeda
Healthy Volunteers
1 trial -
Moexipril HCl/hydrochlorothiazide 15/25 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Mycophenolate Mofetil
Teva Pharma GmbH
Healthy
4 trials -
NAL ER
Trevi Therapeutics
Healthy Participants
2 trials -
NBI-98854 50 mg capsule once daily
NEUROCRINE BIOSCIENCES INC
Effect of Ketoconazole on the PK of NBI-98854 in Healthy Subjects
1 trial -
ND-003 40mg
BRIGHT MINDS BIOSCIENCES INC.
Healthy
1 trial -
NEPA-23-01
Helsinn Birex Pharmaceuticals
Healthy volunteers
1 trial -
NITRAIS 03/2024
Lacuna Pharma Pty Ltd
healthy subjects
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.